| Authors: |
Kadakia KT; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA., Dash Y; Office of Entrepreneurship and Commercialization, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Abernethy AP; Highlander Health, Dallas, TX, USA., Honig N; Highlander Health, Dallas, TX, USA., Levine RL; Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mazumdar-Shaw K; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Biocon Biologics, Bangalore, India., Vickers SM; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Offodile AC 2nd; Office of Entrepreneurship and Commercialization, Memorial Sloan Kettering Cancer Center, New York, NY, USA. offodia@mskcc.org.; Plastic and Reconstructive Surgery Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA. offodia@mskcc.org. |